Header cover image

Indian (NIFTY) Pharma Industry Analysis

UpdatedJun 16, 2024
DataAggregated Company Financials
Companies162
  • 7D1.7%
  • 3M6.0%
  • 1Y53.9%
  • YTD17.8%

The Pharma industry has gained 1.7% in the last week and Cipla up 4.5%. In the same time, Sanofi India was down 29%. This means that the industry has gained 54% over the past year. Earnings are forecast to grow by 17% annually.

Industry Valuation and Performance

Has the Indian Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 16 Jun 2024₹17.7t₹3.6t₹448.3b33x39.4x5x
Tue, 14 May 2024₹16.9t₹3.5t₹428.8b33.8x39.4x4.8x
Thu, 11 Apr 2024₹17.1t₹3.5t₹418.9b33.5x40.9x4.9x
Sat, 09 Mar 2024₹17.1t₹3.5t₹418.7b33.4x40.8x4.9x
Mon, 05 Feb 2024₹16.1t₹3.4t₹408.2b35x39.5x4.7x
Wed, 03 Jan 2024₹15.4t₹3.4t₹395.9b34.3x38.9x4.5x
Fri, 01 Dec 2023₹14.3t₹3.4t₹395.1b31.6x36.1x4.2x
Sun, 29 Oct 2023₹12.8t₹3.3t₹375.3b28.8x34.2x3.9x
Tue, 26 Sep 2023₹12.9t₹3.3t₹369.5b29.8x34.9x3.9x
Thu, 24 Aug 2023₹13.0t₹3.3t₹367.1b29.5x35.5x4x
Sat, 22 Jul 2023₹12.2t₹3.2t₹342.2b26.5x35.7x3.9x
Mon, 19 Jun 2023₹11.4t₹3.2t₹342.4b27.1x33.2x3.6x
Wed, 17 May 2023₹10.4t₹3.1t₹309.5b26.6x33.8x3.4x
Fri, 14 Apr 2023₹9.9t₹3.0t₹277.6b25.5x35.5x3.3x
Sun, 12 Mar 2023₹9.4t₹3.0t₹277.5b24.4x33.7x3.1x
Tue, 07 Feb 2023₹9.7t₹3.0t₹285.2b24.1x34x3.3x
Thu, 05 Jan 2023₹9.9t₹2.9t₹274.9b26.7x36x3.5x
Sat, 03 Dec 2022₹10.2t₹2.9t₹274.9b26.2x37.1x3.6x
Mon, 31 Oct 2022₹10.2t₹2.8t₹260.6b23.7x39.1x3.6x
Wed, 28 Sep 2022₹9.6t₹2.8t₹261.9b23.3x36.5x3.4x
Fri, 26 Aug 2022₹9.7t₹2.8t₹261.9b22.9x37x3.5x
Sun, 24 Jul 2022₹9.6t₹2.8t₹273.5b22.5x35.2x3.5x
Tue, 21 Jun 2022₹8.9t₹2.8t₹273.8b19.7x32.5x3.2x
Thu, 19 May 2022₹9.5t₹2.7t₹332.6b21.7x28.6x3.5x
Sat, 16 Apr 2022₹10.2t₹2.7t₹338.0b24.3x30.3x3.8x
Mon, 14 Mar 2022₹9.9t₹2.7t₹337.9b23.4x29.4x3.7x
Wed, 09 Feb 2022₹10.1t₹2.7t₹368.4b24.1x27.4x3.8x
Fri, 07 Jan 2022₹10.7t₹2.7t₹360.6b36.7x29.6x4x
Sun, 05 Dec 2021₹10.1t₹2.7t₹360.3b22.9x28x3.8x
Tue, 02 Nov 2021₹10.5t₹2.6t₹363.9b24x28.9x4x
Thu, 30 Sep 2021₹10.9t₹2.6t₹375.7b25.8x28.9x4.2x
Sat, 28 Aug 2021₹10.7t₹2.6t₹375.2b23.3x28.4x4.1x
Sun, 04 Jul 2021₹10.7t₹2.6t₹371.5b24x28.9x4.2x
Price to Earnings Ratio

28.9x


Total Market Cap: ₹10.7tTotal Earnings: ₹371.5bTotal Revenue: ₹2.6tTotal Market Cap vs Earnings and Revenue0%0%0%
Indian Pharma Industry Price to Earnings3Y Average 34.1x202220232024
Current Industry PE
  • Investors are optimistic on the Indian Pharmaceuticals industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 39.4x which is higher than its 3-year average PE of 34.1x.
  • The 3-year average PS ratio of 3.9x is lower than the industry's current PS ratio of 5.0x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have grown 6.5% per year over the last three years.
  • Revenues for these companies have grown 11% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Indian Healthcare industry?

IN Market2.66%
Healthcare2.37%
Pharma1.70%
Pharma1.70%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
CIPLA Cipla₹1.56k4.5%
+₹54.5b
55.5%PE30.7x
ZYDUSLIFE Zydus Lifesciences₹1.11k5.1%
+₹54.1b
101.4%PE29.1x
MANKIND Mankind Pharma₹2.24k5.3%
+₹45.3b
38.0%PE46.9x
500660 GlaxoSmithKline Pharmaceuticals₹2.66k6.3%
+₹26.9b
87.7%PE76.5x
NATCOPHARM NATCO Pharma₹1.21k11.8%
+₹23.0b
92.1%PE15.6x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

GLAND

₹1,845.95

Gland Pharma

7D

-0.6%

1Y

82.9%

AJANTPHARM

₹2,378.60

Ajanta Pharma

7D

-1.7%

1Y

61.9%

SUVENPHAR

₹719.15

Suven Pharmaceuticals

7D

10.9%

1Y

48.2%

500674

₹6,838.70

Sanofi India

7D

-28.5%

1Y

-1.3%

APLLTD

₹888.20

Alembic Pharmaceuticals

7D

-3.0%

1Y

44.2%

MANKIND

₹2,240.60

Mankind Pharma

7D

5.3%

1Y

38.0%

AUROPHARMA

₹1,259.00

Aurobindo Pharma

7D

-0.5%

1Y

84.4%

500660

₹2,664.15

GlaxoSmithKline Pharmaceuticals

7D

6.3%

1Y

87.7%

532482

₹461.75

Granules India

7D

-3.5%

1Y

58.0%

500257

₹1,603.85

Lupin

7D

-1.6%

1Y

93.0%